 |
|
Description
Substance: Boldenone Undecylenate
Manufacturer: British Dragon Pharmeceuticals
Pack: 10 ampoules (200 mg/ml)
Active Life: 14-16 days
Drug Class: Anabolic/Androgenic Steroid (for injection)
Average Dose: Men 400-600 mg/week......Women 50-150 mg/week
Acne: Rare
Water Retention: Low
High Blood Pressure: Rare
Liver Toxic: No
Aromatization: Some, about 50% less than testosterone
DHT Conversion: Low
Decrease HPTA function: Moderate
Boldenone Undecylenate is a derivative of testosterone with similar androgenic activity and higher mytrophic activity. Boldenone undecylenate does not convert into estrogens and does not have estrogen-related side effects. Instead, boldenone undecylenate is converted by 5-alpha-reductase into dihydroboldenone and some of it's androgenic effect mediated by dihydroboldenone.
Boldenone Undecylenate increases overall body metabolism rate and increases appetite. Increase in lean body mass and low side effects make this anabolic/androgenic steroid (AAS) a good therapeutic choice for age-related non-genomic muscle degenerative diseases like sarcopenia. The undecylenate ester extends half-life of boldenone in circulation, which, depending on dose, is approximately seven days.
Dosage and administration:
Effective adult dose (male): 200-600mg per week by intramuscular injection
Effective adult dose (female): 50-100mg per week by intramuscular injection
Adverse reactions:
Geriatric patients treated with androgens may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma. The same precautions have to be taken as with other AAS convertible into DHT.
Contraindications:
Contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus.
